What We're Reading: Page 23
Industry reads hand-picked by our editors
Jun 06, 2025
Jun 05, 2025
Jun 04, 2025
-
The Economist
The Alzheimer’s drug pipeline is healthier than you might think
-
The New York Times
From No Hope to a Potential Cure for a Deadly Blood Cancer
-
BioCentury
Lawsuit challenges layoffs at FDA, other HHS agencies
Jun 03, 2025
-
The Wall Street Journal
How Moderna Went From Pandemic Hero to Vaccine Victim
-
The Financial Times
Merck held talks to buy Swiss biotech MoonLake for more than $3bn
-
Bloomberg
AI Drug Startup Touts Promising Advance in Treating Lung Disease
Jun 02, 2025
May 30, 2025
-
The Wall Street Journal
U.S. VCs Race to Tap China’s Biotech Innovation
-
Bloomberg
Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives
-
NOTUS
The MAHA Report Cites Studies That Don’t Exist
May 29, 2025
-
Axios
China’s biotech boom leaves U.S. playing catch-up
-
The Washington Post
CDC blindsided as RFK Jr. changes vaccine recommendations
-
The Atlantic
The Perilous Spread of the Wellness Craze